Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Minimal Access Surgery|January 20, 2022
Does the morphology of the umbilicus influence the incidence of surgical site infections in transumbilical single-incision laparoscopic appendectomy?Dae Jun Lee, Kwang Yong Kim, Soo Kyung Ahn, et al.
World Journal of Emergency Surgery : WJES|July 28, 2017
Delta neutrophil index as an early predictor of acute appendicitis and acute complicated appendicitis in adultsDong Hyuk Shin, Young Suk Cho, Gyu Chong Cho, et al.
Journal of Cancer|June 21, 2021
RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancerSung-Hwa Sohn, Hee Jung Sul, Bohyun Kim, et al.
Scandinavian Journal of Gastroenterology|December 18, 2015
Comparison of endoscopic submucosal dissection and surgical resection for treating gastric subepithelial tumoursJae Seung Soh, Ja Kyung Kim, Hyun Lim, et al.
Human Pathology|March 22, 2016
Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic valueMi Jung Kwon, Jeong Won Kim, Jae Pil Jung, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2016
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancerBoram Han, Joo Young Jung, Hyeong Su Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 23, 2015
Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancerHyeong Su Kim, Min-Hee Ryu, Dae Young Zang, et al.
Gastroenterology Research and Practice|February 4, 2016
Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1Joo Young Jung, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Scandinavian Journal of Gastroenterology|June 23, 2017
Is it beneficial to perform surgical resection in elderly patients more than 80 years old with advanced gastric cancer?Jin Woo Choo, Yeonmi Ju, Hyun Lim, et al.
Cancer Chemotherapy and Pharmacology|January 30, 2015
Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancerHyeong Su Kim, Ho Young Kim, Dae Young Zang, et al.
Pageof 3